CervoMed (CRVO) Accumulated Expenses (2010 - 2026)

CervoMed has reported Accumulated Expenses for 17 years, with the latest figure at $2.2 million in Q1 2026.

• Quarterly Accumulated Expenses rose 476.55% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (up 476.55% YoY) and the FY2025 annual result came in at $3.2 million, up 35.23% from the prior year.
• Accumulated Expenses declined to $2.2 million in Q1 2026 per CRVO's latest filing, from $3.2 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $3.3 million in Q3 2025 and troughed at $206675.0 in Q4 2022.
• A 5-year average of $1.1 million and a median of $492772.0 in 2023 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2022 and 2024: Accumulated Expenses plunged 76.51% in 2022, then jumped 666.14% in 2024.
• Over 5 years, Accumulated Expenses stood at $206675.0 in 2022, then jumped by 49.54% to $309062.0 in 2023, then surged by 666.14% to $2.4 million in 2024, then soared by 35.23% to $3.2 million in 2025, then tumbled by 30.52% to $2.2 million in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $2.2 million, $3.2 million, and $3.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.